New York City, New York, United States of America , 25 Jan 2025 (Viralpressreleases.com) -
Richard H. Davis, President and CEO of Nautilus Biotech Corporation, is calling out Progresso Soup for what he describes as a blatant "knock-off" of his company’s innovative product, JEWISH PENICILLIN™ Cough Drops. Davis launched the patent-pending cough drops—combining the cold-fighting power of chicken soup and menthol—on November 24, 2022. However, Progresso has recently announced a similar product, limited-edition chicken soup-flavored "Soup Drops," dated for release on January 16, 2025.